Cargando…
Rituximab for refractory granulomatous eye disease
OBJECTIVE: To determine the effectiveness of rituximab therapy for patients with granulomatous disease of the eye. METHODS: Retrospective review was undertaken of cases seen at a single institution for ocular antineutrophil cytoplasmic antibody-associated vasculitis or sarcoidosis with persistent oc...
Autores principales: | Lower, Elyse E, Baughman, Robert P, Kaufman, Adam H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468281/ https://www.ncbi.nlm.nih.gov/pubmed/23055686 http://dx.doi.org/10.2147/OPTH.S35521 |
Ejemplares similares
-
World Association for Sarcoidosis and Other Granulomatous Disease (WASOG) Centers of Excellence
por: Baughman, Robert P, et al.
Publicado: (2021) -
Rituximab as an Alternative Treatment for Refractory Granulomatous Hypophysitis
por: Nokhbehzaeim, Mahrokh, et al.
Publicado: (2021) -
Granulomatous-Lymphocytic Interstitial Lung Disease Mimicking Sarcoidosis
por: Perlman, David M, et al.
Publicado: (2021) -
Very Severe and Refractory Noninfectious Cystitis in Patients with Systemic Lupus Erythematosus: Potential Role of Rituximab Therapy
por: Ocampo-Piraquive, Vanessa, et al.
Publicado: (2021) -
Goldilocks, vitamin D and sarcoidosis
por: Baughman, Robert P, et al.
Publicado: (2014)